Navigation Links
AGA Institute applauds delay of Aetna sedation restrictions
Date:2/27/2008

Aetna has announced that, based on input from the AGA Institute and discussions with a number of gastroenterologists, it will not implement Clinical Policy Bulletin 0740 on April 1, 2008, as planned. This policy would have restricted the use of an anesthesia professional in standard upper or lower endoscopic procedures, including colonoscopy, for average-risk patients.

Last month, we contacted Aetna on behalf of AGA members to express concern that this policy could negatively impact colorectal cancer screening rates, which are already discouragingly low. The AGA Institute commends Aetna for listening to our concerns. Aetna will now delay implementation until patient-friendly alternatives for sedation -- which will not require an anesthesiologist -- are approved by the FDA.

Along with our sister GI societies, we look forward to addressing concerns about payer sedation policies. Our goal is to ensure that payment policies do not pose a barrier to patients receiving medically necessary colorectal cancer screening and other endoscopic services.

Aetna has engaged in an exchange of information and viewpoints with our society regarding the possible public health impact of this policy, said Joel V. Brill, MD, AGAF, chair of the American Gastroenterological Association (AGA) Institute practice management and economic committee. "The AGA Institute commends Aetna for listening to our concerns. We are dedicated to working with all stakeholders involved to provide clear recommendations to physicians, patients, purchasers and payers regarding the appropriate use of sedation for endoscopic procedures."

As noted in the August 2007 AGA Institute Review of Endoscopic Sedation. the AGA encourages practitioners to develop a structured sedation protocol suited to the needs of their patients and practice. We are committed to ensuring patients have access to medically necessary technologies, pharmaceuticals and services delivered by appropriately trained health-care professionals. Patients should feel confident that they are undergoing colorectal cancer screening and other endoscopic procedures in an environment that promotes safety, patient comfort and quality of care. Ultimately a qualified health-care practitioner should be the decision maker regarding the use and administration of sedation agents in conjunction with the patient.


'/>"/>

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks
2. New Health & Safety Institute Creates Extensive, Centralized Resource for Emergency Care Training
3. Van Andel Institute and Childrens Memorial Research Center of Chicago Form a Partnership to Facilitate Pediatric Research
4. OHSU Cancer Institute research gives hope for chemo holidays for men with advanced prostate cancer
5. Otho S.A. Sprague Memorial Institute awards Rush nearly $125,000 for new patient-safety project
6. Otho S.A. Sprague Memorial Institute awards Rush $230,000 for childhood obesity prevention
7. Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award
8. UNT Health Science Center and The Center for Cancer and Blood Disorders Collaborate on New Institute for Cancer and Blood Disorders
9. China Holdings Announces Starwood Research Institute Initiates Research Coverage
10. OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
11. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Amherst, Massachusetts (PRWEB) , ... March 30, 2017 , ... ... has had great success and feedback from high school and college students who have ... is being held July 7-23 and YFI is now accepting applications for enrollment. ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and ... two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy drink, ...
(Date:3/29/2017)... ... 2017 , ... Based on research from Guardian’s Fourth Annual ... trying to balance both short-term and long-term benefits demands. Are employers struggling ... complexity, companies are finding that the short-term strategies used to control costs, improve ...
(Date:3/29/2017)... Horeb, WI (PRWEB) , ... March 29, 2017 , ... ... patients on early orthodontic treatment and accepting new pediatric patients, with or without a ... help young patients have a better orthodontic outcome and experience. When patients receive early ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition ... report to their offering. ... The ablation device global market is expected to ... 2023. Ablation is the minimally invasive therapeutic tissue ... or diseased tissue removal, to the removal of abnormally conducting cardiac ...
(Date:3/29/2017)... March 29, 2017  NuVasive, Inc. (NASDAQ: NUVA), ... spine surgery with minimally disruptive, procedurally-integrated solutions, today ... clearance of the CoRoent® Small Interbody™ System indicated ... in the cervical spine. This marks the first ... used at up to four contiguous levels. ...
(Date:3/29/2017)... KALAMAZOO, Michigan , USA, March 29, 2017 /PRNewswire/ ... a Company that Cares by People magazine, in partnership ... out of 50 companies on the list. This list ... employees that have succeeded in business while also demonstrating ... and the environment.  To determine the ...
Breaking Medicine Technology: